- ►uic.edu [PDF] DA Fiellin, PG O'Connor - The New England journal of medicine, 2002 - nejm.highwire.org A 30-year-old man reports a two-year history of heroin use. For the past year,
he has been using intranasal heroin every day. He has undergone detoxification
twice at a local opioid treatment program but began using heroin within two ... Cited by 77 - Related articles - BL Direct - All 10 versions
MJ Krantz, PS Mehler - Archives of internal medicine, 2004 - Am Med Assoc Almost 3 million Americans have abused heroin. The most effective treatment for
this concerning epidemic is opioid replacement therapy. Although, from a
historical perspective, acceptance of this therapy has been slow, growing ... Cited by 55 - Related articles - BL Direct - All 4 versions
- ►annals.org [PDF] DP Alford, P Compton, JH Samet - Annals of internal medicine, 2006 - Am Coll Physicians More patients with opioid addiction are receiving opioid agonist therapy (OAT)
with methadone and buprenorphine. As a result, physicians will more frequently
encounter patients receiving OAT who develop acutely painful conditions, ... Cited by 55 - Related articles - BL Direct - All 13 versions
L Amass, W Ling, TE Freese, C Reiber, JJ … - The American journal on addictions/American Academy …, 2004 - pubmedcentral.nih.gov From NIDA's National Drug Abuse Treatment Clinical Trials Network (CTN),
including the Friends Research Institute, Inc., Los Angeles, Calif./Pacific
Region Node (Dr. Amass); UCLA Integrated Substance Abuse Programs, Los ... Cited by 48 - Related articles - BL Direct - All 8 versions
- ►canadadetox.com [PDF] DA Fiellin, MV Pantalon, MC Chawarski, BA … - New England Journal of Medicine, 2006 - content.nejm.org Results The three treatments had similar efficacies with respect to the mean
percentage of opioid-negative urine specimens (standard medical management and
once-weekly medication dispensing, 44 percent; standard medical management ... Cited by 40 - Related articles - BL Direct - All 8 versions
DA Fiellin, H Kleber, JG Trumble-Hejduk, AT … - Journal of substance abuse treatment, 2004 - Elsevier Buprenorphine and buprenorphine/naloxone (BUP) are newly approved for
office-based treatment of opioid dependence. Federal and non-federal regulatory
and monitoring agencies, national and international researchers, national ... Cited by 32 - Related articles - All 12 versions
- ►escholarship.org KA Sporer - Annals of emergency medicine, 2004 - Elsevier The recent approval of office-based treatment for opioid addiction and US Food
and Drug Administration approval of buprenorphine will expand treatment options
for opioid addiction. Buprenorphine is classified as a partial μ opioid ... Cited by 31 - Related articles - All 15 versions
- ►uams.edu [PDF] LA Marsch, WK Bickel, GJ Badger, EA Jacobs - Drug and alcohol dependence, 2005 - Elsevier This randomized clinical trial evaluated the relative efficacy of three
buprenorphine dosing schedules. Opioid-dependent adults were randomly assigned
to receive buprenorphine seven, 3 or 2 days per week for 24 weeks. Daily ... Cited by 23 - Related articles - All 8 versions
- ►nih.gov IL Mintzer, M Eisenberg, M Terra, C MacVane … - Annals of Family Medicine, 2007 - Annals Family Med METHODS We studied a cohort of 99 consecutive patients enrolled in
buprenor-phine-naloxone treatment for opioid dependence at 2 urban primary care
practices: a hospital-based primary care clinic, and a primary care ... Cited by 22 - Related articles - All 14 versions
BJ Turner, C Laine, Y Lin, K Lynch - Archives of Internal Medicine, 2005 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 20 - Related articles - BL Direct - All 4 versions
